Cite
Stone RM, Manley PW, Larson RA, Capdeville R. Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. . Blood Adv. 2018;2(7):787doi: 10.1182/bloodadvances.2018018481.
(2018). Stone RM, Manley PW, Larson RA, Capdeville R. Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. . Blood advances, 2(7), 787. https://doi.org/10.1182/bloodadvances.2018018481
"Stone RM, Manley PW, Larson RA, Capdeville R. Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. ." Blood advances vol. 2,7 (2018): 787. doi: https://doi.org/10.1182/bloodadvances.2018018481
Stone RM, Manley PW, Larson RA, Capdeville R. Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. . Blood Adv. 2018 Apr 10;2(7):787. doi: 10.1182/bloodadvances.2018018481. PMID: 29618463; PMCID: PMC5894266.
Copy
Download .nbib
